55 research outputs found
OpÄe preporuke za lijeÄenje aneurizmatskog subarahnoidnog krvarenja
Subarachnoid hemorrhage is a neurologic emergency and a detrimental cerebrovascular event with a high rate of death and complications. Recommendations have been developed and based on literature search, evaluation of the results of large international clinical trials, collective experience of the authors, and endorsed by the Croatian Society of Neurovascular Disorders, Croatian Society of Neurology including Section for Neurocritical Care, Croatian Neurosurgical Society, Croatian Society for Difficult Airway Management and Croatian Medical Association. The aim of these guidelines is to provide current and comprehensive recommendations and to assist physicians in making appropriate decisions in the management of subarachnoid hemorrhage. Evidence based information on the epidemiology, risk factors and prognosis, as well as recommendations on diagnostic work up, monitoring and management are provided, with regard to treatment possibilities in Croatia.Subarahnoidno krvarenje je hitno neuroloÅ”ko stanje s visokom stopom smrtnosti i komplikacija. Preporuke su temeljene na dostupnoj literaturi, rezultatima velikih meÄunarodnih kliniÄkih ispitivanja i kolektivnom iskustvu autora, a prihvaÄene od strane Hrvatskoga druÅ”tva za neurovaskularne poremeÄaje, Hrvatskoga druÅ”tva za neurologiju ukljuÄivo i Sekciju za intenzivnu neurologiju, Hrvatskoga druÅ”tva za neurokirurgiju, Hrvatskoga druÅ”tva za zbrinjavanje otežanog
diÅ”nog puta i Hrvatskoga lijeÄniÄkog zbora. Cilj ovih preporuka je pomoÄ lijeÄnicima u donoÅ”enju odgovarajuÄih odluka u dijagnostici i lijeÄenju bolesnika sa subarahnoidnim krvarenjem
Preporuke za lijeÄenje komplikacija u bolesnika nakon aneurizmatskog subarahnoidnog krvarenja
These are evidence based guidelines for the management of medical complications in patients following aneurysmal subarachnoid hemorrhage, developed and endorsed by the Croatian Society of Neurovascular Disorders, Croatian Society of Neurology including Section for Neurocritical Care, Croatian Neurosurgical Society, Croatian Society for Difficult Airway Management and Croatian Medical Association. They consist of recommendations for best monitoring,
medical treatment and interventions based on the literature, evaluation of the results of large international clinical trials, and collective experience of the authors.Predstavljamo smjernice za lijeÄenje komplikacija u bolesnika nakon aneurizmatskog subarahnoidnog krvarenja temeljene na dokazima, a prihvaÄene od strane Hrvatskoga druÅ”tva za neurovaskularne poremeÄaje, Hrvatskoga druÅ”tva za neurologiju ukljuÄivo i Sekciju za intenzivnu neurologiju, Hrvatskoga druÅ”tva za neurokirurgiju, Hrvatskoga druÅ”tva za zbrinjavanje otežanog diÅ”nog puta i Hrvatskoga lijeÄniÄkog zbora. Sastoje se od preporuka za zbrinjavanje, praÄenje i lijeÄenje bolesnika nakon aneurizmatskog subarahnoidnog krvarenja, temeljenih na dostupnoj literaturi, rezultatima velikih meÄunarodnih kliniÄkih ispitivanja i kolektivnog iskustva autora
Äetvrti svjetski kongres o moždanom udaru Melbourne, Australija , 25-29. studenoga 2000. g.
MetaboliÄke encefalopatije
Metabolic encephalopathies may be important complications of many diseases in patients treated at intensive care units. The term metabolic encephalopathies encompass a large variety of different conditions of the brain. Neurologic signs of metabolic encephalopathies, ancillary tests, differential diagnosis, etiology, pathophysiology and treatment are discussed in this review. Metabolic encephalopathies are usually multifactorial in origin and play an important role not only as diseases per se but also for monitoring the severity of decompensating organ functions during deteriorating primary diseases.MetaboliÄke encefalopatije su znaÄajne komplikacije koje se javljaju u mnogih bolesnika lijeÄenih u jedinicama intenzivnog lijeÄenja. Termin "metaboliÄke encefalopatije" odnosi se na Å”irok spektar poremeÄaja funkcije mozga za vrijeme teÅ”ke, kritiÄne bolesti. U ovom Älanku prikazani su neuroloÅ”ki simptomi, moguÄnosti dijagnostiÄkih metoda, kao i etiologija, patofiziologija te terapija metaboliÄkih encefalopatija. MetaboliÄke encefalopatije su u svojoj osnovi multifaktorijalne, a prepoznavanje njihovih simptoma ima važnu ulogu u ranom otkrivanju zatajivanja organskih sustava za vrijeme pogorÅ”avanja osnovne bolesti
Treatment of Stroke
Smanjiti oÅ”teÄenje mozga zbog ishemije i neuroloÅ”kog
deficita kao posljedice moždanog udara osnovni je
cilj lijeÄenja. Zona koja okružuje srediÅ”nji dio ishemije u kojoj
je prisutan djelomiÄan poremeÄaj energetskog kapaciteta
naziva se penumbrom. Najvažnije je otpoÄeti lijeÄenje Å”to
ranije u specijaliziranim jedinicama intenzivnog lijeÄenja (JIL),
i to unutar 3 do 6 sati od poÄetka bolesti. Osnovno je potvrditi
dijagnozu te iskljuÄiti stanja koja mogu pokazivati kliniÄku
sliku moždanog udara a primjena specifiÄnog lijeÄenja može
i pogorÅ”ati ishod. SadaÅ”nje lijeÄenje akutnog ishemijskog
udara ograniÄeno je na malen broj specifiÄne terapije i vrlo
uzak vremenski prozor. JoÅ” uvijek se mnogi lijekovi rutinski
primjenjuju u pogreŔnom uvjerenju da su djelotvorni i sigurni
za bolesnika. Sva dosadaŔnja saznanja uvode kao imperativ
Å”to raniji poÄetak lijeÄenja, a to nameÄe kao najvažniji zadatak
edukaciju kako zdravstvenog osoblja tako i Ŕire javnosti.The main goal of treatment is to lessen the
brain damage due to ischemia and the neurological deficit due
to stroke. The zone encircling the ischemic part with partial disturbance
of energetic capacity is called penumbra. Most important
is to start the treatment as early as possible in specialized
intensive care units (ICU), within 3 to 6 hours from the onset of
the disease. The basic aim is to confirm the diagnosis and
exclude the states that can show the features of stroke, and
the application of specific treatment can even worsen the outcome.
The current treatment of ischemic stroke is limited to a
small number of specific therapeutic procedures and very narrow
frame of time. Still many medications are applied in a
wrong conviction that they are effective and safe for the patient.
All present knowledge take as an imperative the early start of
treatment, and that comprises the important task of educating
health staff and broader population
Ishemijski moždani udar u mladih odraslih osoba: retrospektivna analiza
The aim of the study was to evaluate the profile of ischemic stroke in young adults. Sixty-two cases of ischemic stroke in Croatian subjects aged 26 to 49 years were reviewed. Fifty of these had large infarctions and 12 had lacunar infarctions. The causes of large cerebral infarction were as follows: atherosclerosis 37% of women and 35% of men; cardiac embolism 5% of women and 26% of men; and uncertain causes 31% of women and 23% of men. Among men, the most prominent risk factors were smoking and drinking, whereas among women the leading risk factors were hypertension and hypercholesterolemia. Color Doppler Flow Imaging (CDFI) was pathologic in 48% of female and 33% of male patients.Cilj istraživanja bio je utvrditi karakteristike ishemijskog moždanog udara u mlaÄih osoba. U istraživanje je ukljuÄeno 62 bolesnika u dobi izmeÄu 26 i 49 godina sa ishemijskim moždanim udarom. Uzroci ishemijskog moždanog udara bili su slijedeÄi: ateroskleroza u 37% žena i 35% muÅ”karaca; kardioembolija u 5% žena i 26% muÅ”karaca, a nesigurni uzroci u 31% žena i 23% muÅ”karaca. Pedeset bolesnika imalo je ishemiju u opskrbnom podruÄju jedne ili viÅ”e krvnih žila mozga, dok je njih 12 imalo lakunarnu ishemiju. MeÄu muÅ”karcima, najÄeÅ”Äi riziÄni faktori bili su puÅ”enje i alkoholizam, dok je meÄu ženama, vodeÄi riziÄni faktor bila hipertenzija i hiperkolesterolemija. Kolor dopler je u 48% ženskih bolesnica bio patoloÅ”ki, a meÄu muÅ”karcima u 33% sluÄajeva
MetaboliÄke encefalopatije
Metabolic encephalopathies may be important complications of many diseases in patients treated at intensive care units. The term metabolic encephalopathies encompass a large variety of different conditions of the brain. Neurologic signs of metabolic encephalopathies, ancillary tests, differential diagnosis, etiology, pathophysiology and treatment are discussed in this review. Metabolic encephalopathies are usually multifactorial in origin and play an important role not only as diseases per se but also for monitoring the severity of decompensating organ functions during deteriorating primary diseases.MetaboliÄke encefalopatije su znaÄajne komplikacije koje se javljaju u mnogih bolesnika lijeÄenih u jedinicama intenzivnog lijeÄenja. Termin "metaboliÄke encefalopatije" odnosi se na Å”irok spektar poremeÄaja funkcije mozga za vrijeme teÅ”ke, kritiÄne bolesti. U ovom Älanku prikazani su neuroloÅ”ki simptomi, moguÄnosti dijagnostiÄkih metoda, kao i etiologija, patofiziologija te terapija metaboliÄkih encefalopatija. MetaboliÄke encefalopatije su u svojoj osnovi multifaktorijalne, a prepoznavanje njihovih simptoma ima važnu ulogu u ranom otkrivanju zatajivanja organskih sustava za vrijeme pogorÅ”avanja osnovne bolesti
- ā¦